Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy

Table 1

Details on study population characteristics.

	Variable^
Age	71 yrs (53–78 yrs)
PSA at diagnosis	7 ng/ml (2.5–14.8)
Clinical stage	13 cT1
	5 cT2
	2 cT3
Gleason pattern score	13 GPS = 3 + 3
	7 GPS = 3 + 4
Neoadjuvant/adjuvant hormone therapy	6
BMI	25 (24–32)
Diabetes	1
Hypertension	13
Previous abdominal surgery	12
Use of anticoagulants	2

^Median value is reported together with range for continuous variable and prevalence of patients with the selected feature for dichotomic/categorical variables. PSA: prostate-specific antigen; BMI: body mass index; yrs: years.